The latest closing stock price for Dermata Therapeutics as of September 18, 2024 is 2.25.
An investor who bought $1,000 worth of Dermata Therapeutics stock at the IPO in 2021 would have $-566 today, roughly -1 times their original investment - a -24.32% compound annual growth rate over 3 years.
The all-time high Dermata Therapeutics stock closing price was 6.25 on November 03, 2021.
The Dermata Therapeutics 52-week high stock price is 5.79, which is 157.3% above the current share price.
The Dermata Therapeutics 52-week low stock price is 0.23, which is 89.8% below the current share price.
The average Dermata Therapeutics stock price for the last 52 weeks is 1.22.
An investor who bought $1,000 worth of Dermata Therapeutics stock at the IPO in 2021 would have $-566 today, roughly -1 times their original investment - a -24.32% compound annual growth rate over 3 years.
The all-time high Dermata Therapeutics stock closing price was 6.25 on November 03, 2021.
The Dermata Therapeutics 52-week high stock price is 5.79, which is 157.3% above the current share price.
The Dermata Therapeutics 52-week low stock price is 0.23, which is 89.8% below the current share price.
The average Dermata Therapeutics stock price for the last 52 weeks is 1.22.